|
|
|
| calgb.org > CALGB Web Site Home |
|
| Welcome to the Cancer and Leukemia Group B |
 The Cancer and Leukemia Group B (CALGB) is a national clinical research group sponsored by the National Cancer Institute, with the Central Office headquartered at the University of Chicago and Statistical Center located at Duke University. Founded in 1956, the CALGB brings together clinical oncologists and laboratory investigators to develop better treatments for cancer. CALGB has grown exponentially over the years into a national network of 26 university medical centers, more than 200 community hospitals and more than 3,000 oncology specialists who collaborate in clinical research studies. These studies aim to reduce morbidity and mortality from cancer, relate biological characteristics of cancer to clinical outcomes, and develop new strategies for the early detection and prevention of cancer.
[About CALGB] [About Clinical Trials]
|
| CALGB News |
The Summer 2009 issue of the CAL-GAB newsletter is now available on the CALGB Web site at http://www.calgb.org.
Click this link to view The CAL-GAB: http://www.calgb.org/Public/publications/calgabs/2009/summer2009.pdf
We need your feedback . . . The CAL-GAB Newsletter Survey
Please take a few minutes to complete a survey about The CAL-GAB. Your feedback is appreciated and will be helpful!
To get started, click on this link: http://www.surveymonkey.com/s.aspx?sm=yxYS7taMiUP7zWEdZ3Ymcw_3d_3d
Highlights of this issue include:
- Cover Story -- How Pharmacogenomics Impacts Cancer Research
- Message From the Statistical Center -- The R Statistical Environment in the CALGB Statistical Center
- Spotlight On CALGB Trials -- A Look at Five Trials with Pharmacogenomic Substudies: CALGB 30607, 40101, 40503, 50303 and 80405
- ASCO/CALGB Abstracts -- The CALGB Presents More Than 20 Abstracts at This Year¿s 44th Annual ASCO Meeting
- CALGB Research Awards -- Seven Young Investigators Receive CALGB Research Grants in 2009
- CRA Perspective -- CALGB CRA Orientation Moves from Conference Room to Virtual World
- Oncology Nursing Perspective -- Understanding Symptoms Related to Urogenital Atrophy in Cancer
- IS Corner -- Meet the Staff: CALGB Information Systems Database Development Group
- Training Update -- Do You E-Submit?
- Highlights from the 2009 CALGB Summer Group Meeting
- CALGB Group News -- A Snapshot of the CALGB Central Office Staff; New CALGB Appointments, Honors
- News Briefs in Cancer Research -- FDA Approves Drugs for Advanced Lung and Kidney Cancers; New Tools Available to Promote Clinical Trials; and the Recovery Act (ARRA): At-A-Glance
- Protocol News -- Status on 12 CALGB Studies
- CALGB Support -- Thank You to Donors for CALGB Research and Educational Programs
- CALGB Support Cancer Research -- Give to the Cancer and Leukemia Group B Foundation
Contributions for the December 2009 (winter) issue are welcome and due October 30, 2009. Forward articles, suggestions and other correspondence to jowens@uchicago.edu.
|
| CALGB Results Summaries |
The Cancer and Leukemia Group B is working to make results of CALGB studies more accessible to those touched by cancer and others interested in cancer research in a reader-friendly format. Summaries highlight recently published results and provide resources for more details. To find summaries, search by type of cancer.
|
| CALGB Foundation |
The Cancer and Leukemia Group B Foundation is a nonprofit, tax-exempt foundation that helps the Cancer and Leukemia Group B (CALGB) answer important treatment questions through large-scale clinical trials. Through efforts of the CALGB Foundation in support of CALGB clinical trials and laboratory research, donors can help find new ways to prevent, treat and cure many types of cancer, including leukemia and lymphoma, and cancers of the breast, prostate, lung and GI tract, and help educate the medical community on methods of cancer diagnosis, treatment and prevention.
Here are some recent initiatives supported by the CALGB Foundation:
- New chemotherapy treatments for breast, prostate, lung and colorectal cancer.
- New surgical techniques for breast and colon cancer.
- Genetic studies of breast cancer risk.
- Molecular determinants of response to therapy for breast, colorectal and lung cancers, and leukemia.
- Research that improves the quality of life for cancer patients and their caregivers.
|
|
|
|
|
